Login / Signup

Effectiveness and management of ponatinib as second-line treatment in chronic myeloid leukemia: an analysis from the monitoring registries of the Italian medicines agency (AIFA).

Massimo BrecciaPier Paolo OlimpieriSimone CelantOdoardo Maria OlimpieriFabrizio PaneAlessandra IurloValentina SummaPaolo CorradiniPierluigi Russo
Published in: Annals of hematology (2023)
Keyphrases
  • chronic myeloid leukemia
  • randomized controlled trial
  • systematic review